MiR-144 has been reported to target GSPT1 to inhibit the metastasis of CRC (Xiao et al., 2015), and miR-548c-5p has been found to act as a tumor suppressor in CRC by targeting PGK1 (Ge et al., 2019). Here, PGK1 is linked to colorectal carcinoma.